WHO IRIS
open access
Integrated drug resistance action framework for HIV, hepatitis B and C and sexually transmitted infections, 2026–2030
anti-hiv-agentsantimicrobial-stewardshipantiviral-agentsdrug-resistancehepatitis-bhiv-infectionsmicrobial
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Geospatial and temporal analysis of HIV-1 viral loads and drug resistance in Kwazulu-Natal, South Africa.#327902
- Real-World Effectiveness of All-Oral Direct-Acting Antivirals in Patients With Hepatitis C Virus-Related HCC.#334925
- Implementation and Delivery of Cabotegravir Long Acting Injection for PrEP in a Community Pharmacy Setting.#801505
- Pharmacokinetics of Maraviroc and Boosted Atazanavir Dual Regimen in Stable HIV-infected Patients#886481
- Effectiveness and Safety of New Oral Antivirals for COVID-19#1046396
Record · ID 151807
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive